Log in or Sign up for Free to view tailored content for your specialty!
Gastrointestinal Cancer News
Allogeneic CAR T-cell therapy safe, clinically active in metastatic colorectal cancer
An allogeneic chimeric antigen T-cell therapy showed evidence of clinical activity among patients with metastatic colorectal cancer, according to results of a dose-escalation study presented at Gastrointestinal Cancers Symposium.
Pembrolizumab prolongs PFS vs. chemotherapy for certain patients with colorectal cancer
Pembrolizumab monotherapy demonstrated superior PFS and PFS2 compared with standard-of-care chemotherapy among patients with microsatellite-instability high/mismatch repair-deficient metastatic colorectal cancer.
Log in or Sign up for Free to view tailored content for your specialty!
FDA grants priority review to retifanlimab for anal cancer subset
The FDA granted priority review to retifanlimab for treatment of certain patients with squamous cell carcinoma of the anal canal, according to the agent’s manufacturer.
Circulating tumor DNA predicts relapse risk among patients with colorectal cancer
Circulating tumor DNA analysis outperformed an established biomarker in predicting risk for colorectal cancer recurrence after surgery, according to study results presented at Gastrointestinal Cancers Symposium.
Anal carcinoma risk elevated in individuals with HIV and anogenital warts
Anal carcinoma risk was significantly higher among individuals with HIV and a history of anal or genital warts than among those with no history of these warts, according to a study.
Gut microbiome a potential biomarker for nivolumab efficacy in advanced gastric cancer
The gut microbiome potentially could serve as a biomarker to predict the efficacy of nivolumab among patients with advanced gastric cancer, according to results of the DELIVER trial presented at Gastrointestinal Cancers Symposium.
One-third of colorectal cancer survival disparities a product of treatment gaps
Treatment disparities mediated about one-third of OS differences observed between white and Black patients with stage IV colorectal cancer, according to a retrospective cohort study presented at Gastrointestinal Cancers Symposium.
Early body weight loss linked to shorter OS in gastric, gastroesophageal junction cancer
Body weight loss may predict poor outcomes among patients with metastatic gastric or gastroesophageal junction cancer receiving third-line or later treatment, according to study results presented at Gastrointestinal Cancers Symposium.
FDA grants priority review to Opdivo for gastric, esophageal cancer indications
The FDA granted priority review to nivolumab for two gastrointestinal cancer indications, according to the agent’s manufacturer.
Adding bemarituzumab to chemotherapy improves outcomes in certain gastric cancers
The addition of bemarituzumab to modified FOLFOX6 benefited patients with advanced gastric and gastroesophageal junction cancer with FGFR2b overexpression, according to data presented at Gastrointestinal Cancers Symposium.
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read
-
Headline News
AAP releases first clinical guidance for prescribing opioids to children
September 30, 20242 min read -
Headline News
Oral methotrexate added to usual analgesia reduces pain, stiffness in knee osteoarthritis
September 30, 20242 min read -
Headline News
‘Future-proof’ your practice with these tips
September 27, 20242 min read